US Patent Issued to Chengdu Illumaxbio Technology on March 24 for "Point-of-care testing (POCT) fully-automatic chemiluminescence device based on multi-channel parallel pretreatment technology" (Chinese Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,864, issued on March 24, was assigned to Chengdu Illumaxbio Technology Co. LTD (Chengdu, China).

"Point-of-care testing (POCT) fully-automatic chemiluminescence device based on multi-channel parallel pretreatment technology" was invented by Xingpeng Zhang (Chengdu, China), Le Chang (Chengdu, China) and Rundan Wei (Chengdu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A point-of-care testing (POCT) fully-automatic chemiluminescence device based on a multi-channel parallel pretreatment technology includes a support. The support is provided thereon with a reaction chamber assembly, which reciprocates linearly relative to the support. A multi-c...